ROYAL BANK OF CANADA - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q4 2015$065
+62.5%
0.00%
Q3 2015$040
+471.4%
0.00%
Q1 2015$0
-100.0%
7
-100.0%
0.00%
-100.0%
Q4 2014$31,411,000
+8.4%
2,985,852
-1.2%
0.02%0.0%
Q3 2014$28,983,000
-17.2%
3,022,190
-0.2%
0.02%
-16.7%
Q2 2014$34,991,000
+17.8%
3,029,523
+1.9%
0.02%
+9.1%
Q1 2014$29,716,000
-23.2%
2,971,623
+0.0%
0.02%
-18.5%
Q4 2013$38,690,000
-12.7%
2,971,6160.0%0.03%
-20.6%
Q3 2013$44,337,0002,971,6160.03%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2015
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders